Status:
COMPLETED
Livionex on Reducing Plaque Accumulation and Improving Oral Health in Children
Lead Sponsor:
University of California, San Francisco
Conditions:
Plaque, Dental
Caries, Dental
Eligibility:
All Genders
9-12 years
Phase:
PHASE1
Brief Summary
This is an investigator initiated randomized double-blind pilot study at the UCSF Pediatric Dental Clinics to compare effectiveness of a new toothpaste Livionex Dental Gel with a standard children's t...
Detailed Description
Dental plaque is the primary etiological factor in the initiation of caries, gingival inflammation and subsequent destruction of periodontal tissues. Effective oral hygiene eliminates microbial plaque...
Eligibility Criteria
Inclusion
- Healthy children aged 9 months to 12 years.
- Parent and children are able complete the study procedures.
- Parent/legal guardian willing to allow their child participate and sign informed consent form.
Exclusion
- Parents are unable to understand or participate in study procedures.
- Known allergy to edathamil or known allergy to multiple hygiene and cosmetic products.
Key Trial Info
Start Date :
February 8 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 21 2020
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT04368533
Start Date
February 8 2019
End Date
August 21 2020
Last Update
October 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCSF Pediatric Dentistry Parnassus Clinic
San Francisco, California, United States, 94143